Stockscreener 앱 받기
1,159.60
0.04%
-0.48
시간 외 거래:
1159.50
-0.10
-0.01%
Lilly Eli Co 주식(LLY)의 최신 뉴스
Novo Nordisk: The Pill That Could Close The Gap With Lilly (NYSE:NVO) - Seeking Alpha
The Oral GLP-1 Tracker: Novo's Wegovy pill back on track as Lilly's momentum slows - Fierce Pharma
Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 5 Years - Benzinga
Eli Lilly and Company (NYSE:LLY) Shares Up 1%Here's What Happened - MarketBeat
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK - Yahoo Finance
Eli Lilly will replace lost insulin after Indiana storms - nwitimes.com
Amplitude Therapeutics and Lilly Partner to Advance Trans-Amplifying RNA Vaccine Platform for Infectious Disease - BioPharm International
Stock Split Watch: Is Eli Lilly (LLY) Stock Next? - The Motley Fool
Lilly to work with Boston-based firm to develop RNA vaccine platform - dailyjournal.net
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb - Pharmaceutical Executive
Eli Lilly (NYSE:LLY) Shows Strong Growth and a Compelling Technical Setup - ChartMill
How cost and perception could reshape the GLP-1 market - BioPharma Dive
Eli Lilly and Company $LLY Shares Acquired by Kelleher Financial Advisors - MarketBeat
Private Advisory Group LLC Purchases 2,056 Shares of Eli Lilly and Company $LLY - MarketBeat
M3 Wealth Management LLC Purchases Shares of 2,836 Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Stock Holdings Decreased by SMART Wealth LLC - MarketBeat
Russell Investments Group Ltd. Has $942.43 Million Stake in Eli Lilly and Company $LLY - MarketBeat
Focus Partners Advisor Solutions LLC Has $16.78 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
3,643 Shares in Eli Lilly and Company $LLY Purchased by Bellars Harris Wealth Management LLC - MarketBeat
ABN AMRO Bank N.V. Reduces Stock Position in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company (NYSE:LLY) Stock Price Down 2.6%Time to Sell? - MarketBeat
There’s a Black Market for Eli Lilly’s Unapproved GLP-1 Drug. Here’s Why That’s Bullish - The Motley Fool
Eli Lilly reveals plans for Lehigh Valley construction to avoid traffic problems. Here are the details. - The Morning Call
Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B - TradingKey
Eli Lilly: New type 2 diabetes jab could slash number of injections to one a week - The Independent
Eli Lilly and Company $LLY Stock Position Raised by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Mosaic Family Wealth Partners LLC Grows Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY is Donaldson Capital Management LLC's 7th Largest Position - MarketBeat
Canton Hathaway LLC Has $1.05 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Bought by AlTi Global Inc. - MarketBeat
Upper Macungie planners endorse Eli Lilly plan for manufacturing campus - WFMZ.com
Eli Lilly Price Forecast: The Next Big Stock After Weight-Loss Drug Breakthrough? - Mitrade
Can Eli Lilly Catch Novo Nordisk in the Oral GLP-1 Race? - Yahoo Finance
Eli Lilly and Company (NYSE:LLY) Trading 4.5% HigherHere's Why - MarketBeat
Eli Lilly and Co (LLY) Stock Up 4.5% and Still Undervalued -- GF Score: 96/100 - GuruFocus
Could Eli Lilly Be Worth More Than SpaceX by the End of 2026? - Yahoo Finance
LLY Looks 15.4% Undervalued on GF Value™ Amid New Vaccine Partne - GuruFocus
Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying RNA Vaccines for Infectious Diseases - PR Newswire
Eli Lilly Shares Approach High as 60% Volume Surge Offsets 13% Price Fall - TechStock²
Eli Lilly hits $1 trillion valuation, with stro... - Pluang
Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold? - 24/7 Wall St.
Lilly Stock Rises on Alzheimer Deal: Retatrutide Moat Still Not Fully Priced - Tech Times
How Does LLY's Q2 GLP-1 Portfolio Performance Stack Up Against NVO's? - TradingView
Stock Forecast: The Market is Sleeping on Eli Lilly’s Next $1 Trillion Opportunity - 24/7 Wall St.
Eli Lilly and Company (NYSE:LLY) Reaches New 12-Month HighStill a Buy? - MarketBeat
Eli Lilly and Co Stock (LLY) Moved Up by 5.18% on Aug 19: What Investors Need To Know - TradingKey
Eli Lilly (NYSE:LLY): Is Its Valuation Story Getting Stronger? - Kalkine Media
Eli Lilly stock hits all-time high at 1249.95 USD By Investing.com - Investing.com Nigeria
Why is Eli Lilly stock surging today? - Investing.com
Lilly Turns Lifelong Struggle with Weight Into Story of Hope in ‘A Life Covered’ - Little Black Book | LBBOnline
Inside Eli Lilly’s Pre-Launch Push to Police the Retatrutide Market - thefashionlaw.com
Eli Lilly (NYSE:LLY) Expands Neuroscience Reach With New Drug Deals - Kalkine Media
Lilly Is Trailing In Obesity Pills; How Long Will That Last? - Investor's Business Daily
CNBC Final Trades: Netflix, Eli Lilly, Elanco Animal Health & MoreNetflix (NASDAQ:NFLX), Eli Lilly (NY - Benzinga
OmniAb secures up to $370m Lilly deal for ion channel program - BioXconomy
Janney Montgomery Scott LLC Has $357.98 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat
Parr Mcknight Wealth Management Group LLC Acquires 1,702 Shares of Eli Lilly and Company $LLY - MarketBeat
HighTower Advisors LLC Sells 4,236 Shares of Eli Lilly and Company $LLY - MarketBeat
Convergence Financial LLC Purchases 4,147 Shares of Eli Lilly and Company $LLY - MarketBeat
Fifth Third Bancorp Sells 212,702 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Bought by BLB&B Advisors LLC - MarketBeat
Novo takes first round of oral obesity duel. Can it stay ahead of Lilly? - BioSpace
UnitedHealth Group (UNH) vs. Eli Lilly and Company (LLY): Which Healthcare Stock Offers the Better Dividend? - Yahoo Finance
Why Eli Lilly (LLY) Stock Is Up Today - Yahoo Finance
Eli Lilly (LLY) Adds Neuroscience And Lung Cancer Research Deals - Yahoo Finance
Eli Lilly (NYSE:LLY): What Could Shift the Healthcare Story? - Kalkine Media
Eli Lilly and Company (NYSE:LLY) Stock Price Up 3.7%What's Next? - MarketBeat
Eli Lilly and Company (NYSE:LLY) EVP Sells $7,638,150.00 in Stock - MarketBeat
1.17%
0.58%
자본화:
|
볼륨(24시간):